Advertisement
Screener

NOVAVAX INC (NVAX) Cash Flow Breakdown

NOVAVAX INC Cash Flow Breakdown

Cash flow breakdown shows where NOVAVAX INC's cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $244.63M went out.
  • Fiscal year ended 2025-12-31: from investing, $78.27M went out.
  • Fiscal year ended 2025-12-31: from financing, $27.74M came in.
  • Fiscal year ended 2025-12-31: change in cash, $289.24M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingNew debtStaff share taxNew shares soldNot split outChange in cash
2025-12-31-$244.63M-$78.27M$0.00$27.74M*-$289.24M
2024-12-31-$87.26M-$204.04M$263.27M-$2.69M*-$38.52M
2023-12-31-$713.97M-$58.81M$360.24M-$355.78M*-$765.03M
2022-12-31-$415.94M-$92.98M$249.23M$75.76M*-$179.41M
2021-12-31$322.95M$100.15M$564.86M-$103.15M*$879.52M
2020-12-31-$42.54M-$377.78M$875.62M$109.14M*$566.56M
2019-12-31-$136.62M$38.49M$0.00$97.39M$992.00K*$221.00K
2018-12-31-$184.82M$28.60M$0.00$100.06M$2.75M*-$53.47M
2017-12-31-$144.48M$35.97M$63.42M$1.11M*-$43.83M
2016-12-31-$258.77M$28.02M$0.00$279.85M*$48.76M
2015-12-31-$126.09M-$21.27M$204.28M$4.01M*$60.77M
2014-12-31-$67.01M-$129.83M$107.90M$1.82M*-$87.14M
2013-12-31-$45.36M$16.39M$2.00M$128.65M$102.07M
2012-12-31-$18.23M-$32.26M$500.00K*$54.00M$3.29M
2011-12-31-$23.63M$18.54M$10.98M$6.04M
2010-12-31-$32.85M-$21.27M$23.09M-$30.70M
2009-12-31-$32.83M$2.35M$56.38M-$14.09M*$11.82M

Each quarter (3 month)

Quarter endRunning the businessFrom investingNew debtCommercial paperNew shares soldNot split outChange in cash
2026-06-30-$72.81M*$34.90M*$0.00*$1.20M*
2026-03-31-$32.42M-$28.36M$46.41M-$8.74M*-$23.13M
2025-12-31-$39.48M*$20.48M*$0.00*-$6.60M*
2025-09-30$107.80M*-$136.53M*$0.00*$42.44M*
2025-06-30-$127.46M*$111.10M*$0.00*$0.00*-$1.04M*
2025-03-31-$185.50M-$73.32M$0.00$0.00-$7.06M*-$266.81M
2024-12-31-$173.16M*$144.01M*$0.00*-$3.42M*
2024-09-30-$144.81M*$31.91M*$0.00*
2024-06-30$314.27M*-$372.71M*$256.41M*$1.81M*
2024-03-31-$83.56M-$7.25M$6.86M-$976.00K*-$87.87M
2023-12-31-$176.78M*-$9.08M*$103.25M*-$2.86M*
2023-09-30-$39.66M*-$18.39M*$195.01M*$2.11M*
2023-06-30-$171.94M*-$7.78M*$61.99M*-$651.00K*
2023-03-31-$325.59M-$23.56M$0.00-$354.38M*-$711.90M
2022-12-31-$117.82M*-$22.06M*$69.84M*$121.59M*
2022-09-30-$38.71M*-$29.52M*$0.00*-$30.98M*
2022-06-30-$170.90M*-$24.58M*$0.00*$4.66M*
2022-03-31-$88.51M-$16.83M$179.38M-$19.52M*$55.84M
2021-12-31-$342.41M*-$16.36M*$0.00*-$60.71M*
2021-09-30-$142.14M*-$12.19M*$0.00*-$15.72M*
2021-06-30$144.41M*-$12.90M*$0.00*-$38.84M*
2021-03-31$663.09M$141.61M$564.86M$12.13M*$1.38B
2020-12-31-$128.57M*-$31.12M*$428.55M*-$23.94M*
2020-09-30-$6.50M*-$100.71M*$53.31M*-$75.69M*
2020-06-30$115.63M*-$188.22M*$207.84M*$208.77M*
2020-03-31-$23.11M-$57.73M$185.92M$105.01M
2019-12-31-$23.74M*-$216.00K*$30.17M*
2019-09-30-$32.26M*$17.97M*$11.98M*
2019-06-30-$30.01M*$2.02M*$3.00K*
2019-03-31-$50.61M$18.71M$55.24M$942.00K*$24.24M
2018-12-31-$45.27M*$48.32M*$3.57M*
2018-09-30-$33.51M*$8.00M*$0.00*$1.02M*
2018-06-30-$39.97M*-$48.30M*$53.89M*
2018-03-31-$66.08M$20.59M$42.60M$1.32M*-$1.59M
2017-12-31-$43.40M*$16.76M*$17.40M*$2.06M*
2017-09-30-$44.18M*$41.96M*$23.29M*$28.45M*
2017-06-30-$12.40M*$2.53M*$8.15M*-$20.05M*
2017-03-31-$44.50M-$25.28M$14.59M$779.00K*-$54.39M
2016-12-31-$64.55M*$85.91M*$0.00*$765.00K*$24.41M*
2016-09-30-$62.36M*$92.57M*$0.00*$30.55M*
2016-06-30-$62.03M*$18.98M*$0.00*-$42.83M*
2016-03-31-$69.83M-$169.44M$0.00$278.35M*$39.12M
2015-12-31-$54.75M*$9.56M*$0.00*-$45.04M*
2015-09-30-$28.53M*-$9.21M*$7.18M*$1.34M*-$29.24M*
2015-06-30-$12.32M*-$39.41M*$3.47M*$590.00K*-$47.67M*
2015-03-31-$30.49M$17.79M$193.62M$1.88M*$182.72M
2014-12-31-$19.77M*$17.35M*$0.00*-$2.14M*
2014-09-30-$15.87M*-$54.10M*-$4.00K*$585.00K*-$69.38M*
2014-06-30-$10.94M*-$102.78M*$107.90M*-$6.06M*
2014-03-31-$20.43M$9.70M$0.00$1.17M*-$9.55M
2013-12-31-$12.26M*$9.16M*$500.00K*-$11.00K*-$3.02M*
2013-09-30-$14.88M*$15.41M*$0.00*$118.64M*$730.00K*$119.92M*
2013-06-30-$7.63M*-$3.21M*$3.59M*$798.00K*-$6.45M*
2013-03-31-$10.58M-$4.97M$6.42M$756.00K*-$8.38M
2012-12-31-$3.25M*-$17.11M*$27.08M*$6.66M*
2012-09-30-$4.63M*-$7.35M*$6.90M*-$4.60M*
2012-06-30-$6.13M*-$4.53M*$12.10M*$1.46M*
2012-03-31-$4.22M-$3.27M$7.92M-$664.00K*-$231.00K
2011-12-31-$2.87M*$804.00K*$1.80M*-$214.00K*
2011-09-30-$3.32M*$3.62M*$902.00K*$1.23M*
2011-06-30-$8.40M*$6.13M*$6.96M*$4.73M*
2011-03-31-$9.04M$7.99M$1.32M$297.00K
2010-12-31-$5.81M*-$3.30M*$975.00K*-$8.15M*
2010-09-30-$8.32M*-$3.96M*$19.05M*$6.77M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80
Vericel Corp (VCEL)United States$2.011B93.97
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16